GPT and Thrombocytopenia: Significant side effects occurred in 48.3% of patients, of which thrombocytopenia occurred in 12 (41.4%), an increase in aspartate aminotransferase in 4 (13.8%), an increase in γGT in 2 (6, 9%), increase in ALT in 2 (6.9%), and diarrhea in 2 (6.9%) patients.